HeadInvest LLC’s Evolent Health EVH Stock Holding History

HeadInvest LLC’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-225	Closed	-$6.05K	–	368
2023 Q3	$6.05K	Buy	+225	New	+$6.25K	﹤0.01%	613

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

HeadInvest LLC's EVH Position: Q4 2023 in Review

HeadInvest LLC sold out of Evolent Health (EVH) in Q4 2023, closing a stake of 225 shares — an estimated $6.05K sold.

HeadInvest LLC first reported a position in EVH in Q3 2023 and held it in 1 quarter. The position peaked at $6.05K in Q3 2023. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

HeadInvest LLC reported no remaining Evolent Health position as of Q4 2023 after selling out during the quarter.
HeadInvest LLC sold 225 Evolent Health shares in Q4 2023, an estimated $6.05K.
HeadInvest LLC first reported a position in Evolent Health in Q3 2023 and held it in 1 quarter.
HeadInvest LLC's Evolent Health position peaked at $6.05K in Q3 2023.
234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on HeadInvest LLC's 13F filing for Q4 2023, filed 12 Feb 2024.